| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| bupivacaine hydrochloride monohydrate | Injection, solution | 52.7 mg | Current | Unavailable | Manufacturing | 8/11/2024 |
| amlodipine besilate | Tablet, uncoated | 6.94 mg | Anticipated | Available | Manufacturing | 8/11/2024 |
| midazolam | Injection, solution | 5 mg/mL | Current | Limited Availability | Manufacturing | 8/11/2024 |
| sodium pyrophosphate | Injection, powder for | 30 mg | Current | Emergency Supply Only | Manufacturing | 8/11/2024 |
| potassium clavulanate~amoxicillin trihydrate | Suspension, powder for | 7.45 mg/mL~28.7 mg/mL | Current | Unavailable | Manufacturing | 8/11/2024 |
| benzathine benzylpenicillin tetrahydrate | Injection, suspension | 1200000 USP Unit | Anticipated | Available | Manufacturing | 8/11/2024 |
| iopromide | Injection, solution | 498.72 mg/mL | Resolved | Available | Unexpected increase in consumer demand | 8/11/2024 |
| hydrocortisone sodium succinate | Injection, powder for | 334.25 mg | Resolved | Available | Manufacturing | 8/11/2024 |
| acetylcysteine | Injection, concentrated | 2 g | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 8/11/2024 |
| diazepam | Tablet, uncoated | 2 mg | Anticipated | Available | Manufacturing | 8/11/2024 |
| risperidone | Tablet, film coated | 2 mg | Anticipated | Available | Unexpected increase in consumer demand | 8/11/2024 |
| zolmitriptan | Tablet, film coated | 2.5 mg | Current | Unavailable | Manufacturing | 8/11/2024 |
| duloxetine hydrochloride | Capsule, enteric | 33.66 mg | Current | Unavailable | Unexpected increase in consumer demand | 8/11/2024 |
| citalopram hydrobromide | Tablet, film coated | 49.98 mg | Current | Unavailable | Manufacturing | 8/11/2024 |
| meloxicam | Capsule, hard | 15 mg | Resolved | Available | Manufacturing | 8/11/2024 |
| anastrozole | Tablet, film coated | 1 mg | Current | Limited Availability | Manufacturing | 8/11/2024 |
| fluorouracil | Injection, solution | 50 mg/mL | Current | Limited Availability | Manufacturing | 8/11/2024 |
| mesalazine | Tablet, enteric coated | 250 mg | Anticipated | Available | Manufacturing | 8/11/2024 |
| benzathine benzylpenicillin tetrahydrate | Injection, suspension | 600000 USP Unit | Current | Unavailable | Manufacturing | 8/11/2024 |
| nebivolol hydrochloride | Tablet | 1.363 mg | Current | Limited Availability | Manufacturing | 8/11/2024 |
| nebivolol hydrochloride | Tablet | 5.45 mg | Current | Limited Availability | Manufacturing | 8/11/2024 |
| nebivolol hydrochloride | Tablet | 10.9 mg | Resolved | Available | Manufacturing | 8/11/2024 |
| hydrochlorothiazide~amlodipine besilate~olmesartan medoxomil | Tablet, film coated | 12.5 mg~6.95 mg~40 mg | Resolved | Available | Manufacturing | 8/11/2024 |
| tamoxifen citrate | Tablet | 30.34 mg | Current | Limited Availability | Manufacturing | 8/11/2024 |
| lurasidone hydrochloride | Tablet, film coated | 80 mg | Resolved | Available | Manufacturing | 8/11/2024 |
| lurasidone hydrochloride | Tablet, film coated | 40 mg | Resolved | Available | Manufacturing | 8/11/2024 |
| lanreotide acetate | Injection, solution | 100 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 8/11/2024 |
| lanreotide acetate | Injection, solution | 66.67 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 8/11/2024 |
| daptomycin | Inhalation, powder for | 350 mg | Current | Limited Availability | Manufacturing | 8/11/2024 |
| morphine sulfate pentahydrate | Tablet, film coated | 10 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 8/11/2024 |
| clindamycin phosphate | Cream | 22.8 mg/g | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 8/11/2024 |
| clonazepam | Tablet, uncoated | .5 mg | Current | Limited Availability | Manufacturing | 8/11/2024 |
| cabergoline | Tablet, uncoated | 2 mg | Current | Limited Availability | Manufacturing | 8/11/2024 |
| baclofen | Tablet, uncoated | 25 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 8/11/2024 |
| adrenaline (epinephrine) acid tartrate | Injection, solution | 1.82 mg/mL | Anticipated | Available | Manufacturing | 7/11/2024 |
| fluconazole | Capsule, hard | 200 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 7/11/2024 |
| olanzapine | Tablet, orally disintegrating | 20 mg | Anticipated | Available | Manufacturing | 7/11/2024 |
| dutasteride~tamsulosin hydrochloride | Capsule, modified release | 500 microgram~400 microgram | Current | Limited Availability | Manufacturing | 7/11/2024 |
| tacrolimus monohydrate | Capsule, hard | 1.022 mg | Anticipated | Available | Manufacturing | 7/11/2024 |
| bisoprolol fumarate | Tablet | 10 mg | Current | Unavailable | Manufacturing | 7/11/2024 |
| levetiracetam | Tablet, film coated | 1000 mg | Current | Unavailable | Manufacturing | 7/11/2024 |
| escitalopram oxalate | Tablet, film coated | 12.74 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 7/11/2024 |
| escitalopram oxalate | Tablet, film coated | 25.47 mg | Current | Unavailable | Manufacturing | 7/11/2024 |
| carboplatin | Injection, solution | 450 mg | Anticipated | Available | Manufacturing | 7/11/2024 |
| tadalafil | Tablet, film coated | 20 mg | Current | Limited Availability | Manufacturing | 7/11/2024 |
| simvastatin | Tablet, film coated | 20 mg | Current | Unavailable | Manufacturing | 7/11/2024 |
| noradrenaline (norepinephrine) acid tartrate monohydrate | Injection, concentrated | 8 mg | Current | Limited Availability | Manufacturing | 7/11/2024 |
| hydrochlorothiazide~irbesartan | Tablet, film coated | 12.5 mg~300 mg | Anticipated | Available | Manufacturing | 7/11/2024 |
| cerliponase alfa | Injection, solution | 30 mg/mL | Resolved | Available | Manufacturing | 7/11/2024 |
| dutasteride~tamsulosin hydrochloride | Capsule, modified release | 500 microgram~400 microgram | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 7/11/2024 |
| estradiol | Drug delivery system, transdermal | .39 mg | Current | Unavailable | Manufacturing | 7/11/2024 |
| estradiol | Drug delivery system, transdermal | 1.56 mg | Current | Unavailable | Manufacturing | 7/11/2024 |
| trimethoprim | Tablet, uncoated | 300 mg | Current | Limited Availability | Manufacturing | 7/11/2024 |
| flecainide acetate | Tablet | 50 mg | Current | Unavailable | Manufacturing | 7/11/2024 |
| cefaclor monohydrate | Oral Liquid, powder for | 52.45 mg/mL | Current | Unavailable | Unexpected increase in consumer demand | 7/11/2024 |
| potassium clavulanate~amoxicillin trihydrate | Tablet, film coated | 149 mg~574 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 7/11/2024 |
| tirzepatide | Injection, solution | 7.5 mg | Current | Unavailable | Commercial Changes / Commercial viability | 7/11/2024 |
| tirzepatide | Injection, solution | 12.5 mg | Current | Unavailable | Commercial Changes / Commercial viability | 7/11/2024 |
| tirzepatide | Injection, solution | 10 mg | Current | Unavailable | Commercial Changes / Commercial viability | 7/11/2024 |
| tirzepatide | Injection, solution | 2.5 mg | Current | Unavailable | Commercial Changes / Commercial viability | 7/11/2024 |
| nizatidine | Capsule | 300 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 7/11/2024 |
| clarithromycin | Tablet, film coated | 250 mg | Current | Limited Availability | Unexpected increase in consumer demand | 7/11/2024 |
| fluticasone furoate | Spray, suspension | 27.5 microgram | Anticipated | Available | Unexpected increase in consumer demand | 6/11/2024 |
| silver sulfadiazine | Cream | 10 mg/g | Current | Unavailable | Manufacturing | 6/11/2024 |
| mycophenolate mofetil | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 6/11/2024 |
| sildenafil citrate | Tablet, film coated | 28.1 mg | Current | Limited Availability | Manufacturing | 6/11/2024 |
| mycophenolate mofetil | Tablet, film coated | 500 mg | Resolved | Available | Manufacturing | 6/11/2024 |
| esomeprazole | Capsule, enteric | 40 mg | Current | Limited Availability | Manufacturing | 6/11/2024 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Unavailable | Unexpected increase in consumer demand | 6/11/2024 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Unavailable | Unexpected increase in consumer demand | 6/11/2024 |
| atomoxetine hydrochloride | Capsule, hard | 91.2 mg | Resolved | Available | Manufacturing | 6/11/2024 |
| atorvastatin calcium trihydrate | Tablet, film coated | 86.751 mg | Current | Limited Availability | Manufacturing | 6/11/2024 |
| norethisterone acetate~estradiol~estradiol | Drug delivery system, transdermal | 2.7 mg~.78 mg~.62 mg | Current | Limited Availability | Manufacturing | 6/11/2024 |
| norethisterone acetate~estradiol~estradiol | Drug delivery system, transdermal | 4.8 mg~.512 mg~.78 mg | Current | Limited Availability | Manufacturing | 6/11/2024 |
| estradiol | Drug delivery system, transdermal | .585 mg | Current | Unavailable | Manufacturing | 6/11/2024 |
| estradiol | Drug delivery system, transdermal | .78 mg | Current | Unavailable | Manufacturing | 6/11/2024 |
| estradiol | Drug delivery system, transdermal | 1.17 mg | Current | Unavailable | Manufacturing | 6/11/2024 |
| chloramphenicol | Eye Drops, solution | 5 mg/mL | Current | Unavailable | Manufacturing | 6/11/2024 |
| melatonin | Capsule, hard | 5 mg | Current | Limited Availability | Unexpected increase in consumer demand | 6/11/2024 |
| estradiol~norethisterone acetate | Drug delivery system, transdermal | .62 mg~2.7 mg | Current | Unavailable | Manufacturing | 6/11/2024 |
| norethisterone acetate~estradiol | Drug delivery system, transdermal | 4.8 mg~.512 mg | Current | Limited Availability | Manufacturing | 6/11/2024 |
| risperidone | Tablet, film coated | 4 mg | Current | Unavailable | Manufacturing | 5/11/2024 |
| oxytocin | Injection, solution | 10 IU | Current | Unavailable | Manufacturing | 5/11/2024 |
| progesterone | Pessary, compressed | 100 mg | Current | Unavailable | Manufacturing | 5/11/2024 |
| citalopram hydrobromide | Tablet, film coated | 12.495 mg | Anticipated | Available | Manufacturing | 5/11/2024 |
| citalopram hydrobromide | Tablet, film coated | 49.98 mg | Anticipated | Available | Manufacturing | 5/11/2024 |
| azithromycin dihydrate | Tablet, film coated | 524 mg | Current | Unavailable | Manufacturing | 5/11/2024 |
| hydrochlorothiazide~irbesartan | Tablet, film coated | 25 mg~300 mg | Anticipated | Available | Manufacturing | 5/11/2024 |
| tenofovir disoproxil fumarate~emtricitabine | Tablet, film coated | 300 mg~200 mg | Resolved | Available | Manufacturing | 5/11/2024 |
| tadalafil | Tablet, film coated | 10 mg | Current | Unavailable | Manufacturing | 5/11/2024 |
| tadalafil | Tablet, film coated | 20 mg | Current | Limited Availability | Manufacturing | 5/11/2024 |
| timolol maleate | Eye Drops, solution | 6.83 mg/mL | Anticipated | Available | Commercial Changes / Commercial viability | 5/11/2024 |
| levothyroxine sodium | Tablet | 50 microgram | Current | Unavailable | Manufacturing | 5/11/2024 |
| melatonin | Oral Liquid, solution | 1 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 5/11/2024 |
| timolol maleate | Eye Drops, solution | 6.84 mg/mL | Current | Unavailable | Manufacturing | 5/11/2024 |
| gefitinib | Tablet, film coated | 250 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 5/11/2024 |
| ciprofloxacin hydrochloride | Tablet, film coated | 832.5 mg | Current | Unavailable | Manufacturing | 4/11/2024 |
| morphine hydrochloride trihydrate | Oral Liquid, solution | 2 mg/mL | Resolved | Available | Commercial Changes / Commercial viability | 4/11/2024 |
| morphine hydrochloride trihydrate | Oral Liquid, solution | 10 mg/mL | Current | Unavailable | Commercial Changes / Commercial viability | 4/11/2024 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Limited Availability | Manufacturing | 4/11/2024 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 4/11/2024 |
| irbesartan | Tablet, film coated | 300 mg | Current | Unavailable | Manufacturing | 4/11/2024 |
| pregabalin | Capsule, hard | 150 mg | Anticipated | Available | Manufacturing | 4/11/2024 |
| quinagolide hydrochloride | Tablet, uncoated | .0819 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 4/11/2024 |
| verapamil hydrochloride | Tablet, modified release | 180 mg | Current | Limited Availability | Manufacturing | 4/11/2024 |
| morphine sulfate pentahydrate | Capsule, modified release | 90 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 4/11/2024 |
| clonidine hydrochloride | Tablet, uncoated | 150 microgram | Current | Limited Availability | Manufacturing | 4/11/2024 |
2024年11月11日